Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision label has been updated from v3.4.1 to v3.4.2, a minor update with no changes to the study data or display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 as the site version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedMinor UI and wording updates were made, including glossary show/hide options, capitalization tweaks in QC criteria labels, and revision/version strings (v3.4.0 added, v3.3.4 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision: v3.3.4 appears in the page revision history, replacing v3.3.3; no study content or essential information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.